Cargando…

Non-Hodgkin Lymphoma Prognostic Factors and Targets /

Recent developments in the therapy of non-Hodgkin lymphoma have improved response and survival rates in patients with these conditions. This book is focused on the biology, prognostic factors and novel targets of non-Hodgkin lymphoma. We believe that understanding the pathophysiology of non-Hodgkin...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Quesenberry, Peter J. (Editor ), Castillo, Jorge J. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York, NY : Springer New York : Imprint: Humana, 2013.
Edición:1st ed. 2013.
Colección:Cancer Drug Discovery and Development,
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-1-4614-5851-7
003 DE-He213
005 20220119080305.0
007 cr nn 008mamaa
008 130131s2013 xxu| s |||| 0|eng d
020 |a 9781461458517  |9 978-1-4614-5851-7 
024 7 |a 10.1007/978-1-4614-5851-7  |2 doi 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 571.978  |2 23 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Non-Hodgkin Lymphoma  |h [electronic resource] :  |b Prognostic Factors and Targets /  |c edited by Peter J. Quesenberry, Jorge J. Castillo. 
250 |a 1st ed. 2013. 
264 1 |a New York, NY :  |b Springer New York :  |b Imprint: Humana,  |c 2013. 
300 |a VI, 304 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Cancer Drug Discovery and Development,  |x 2196-9914 
505 0 |a Cancer Stem Cells: A Matter of Perspective -- B and T-cell development -- HIV lymphomagenesis -- Epstein-Barr Virus Lymphomagenesis and Therapeutic Targets -- Antigen driven lymphomagenesis -- Pre-clinical lymphoma models -- Prognostic factors in B-cell lymphoma -- Prognostic factors in T-cell lymphoma -- Prognostic factors in HIV-associated lymphoma -- Future directions on the treatment of aggressive non-Hodgkin lymphoma -- New monoclonal antibodies for indolent non-Hodgkin lymphomas -- Current therapies for T-cell lymphoma -- Stem Cell Transplantation for lymphoma -- Autologous stem cell transplantation in non-Hodgkin lymphoma -- The role of Stem Cell Transplantation for HIV-associated lymphoma -- Stem Cell Transplantation for T-cell lymphoma -- Index. 
520 |a Recent developments in the therapy of non-Hodgkin lymphoma have improved response and survival rates in patients with these conditions. This book is focused on the biology, prognostic factors and novel targets of non-Hodgkin lymphoma. We believe that understanding the pathophysiology of non-Hodgkin lymphoma provides a mean to improve its risk-stratification and treatment. This book is intended for medical and healthcare professionals involved in the research and clinical care of patients with non-Hodgkin lymphoma. 
650 0 |a Cancer. 
650 0 |a Pharmacology. 
650 1 4 |a Cancer Biology. 
650 2 4 |a Pharmacology. 
700 1 |a Quesenberry, Peter J.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Castillo, Jorge J.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781461458524 
776 0 8 |i Printed edition:  |z 9781489994196 
776 0 8 |i Printed edition:  |z 9781461458500 
830 0 |a Cancer Drug Discovery and Development,  |x 2196-9914 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-1-4614-5851-7  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)